You searched for "THRIVE"
Wraparound IBD care pathway for enhanced patient outcomes
BIOHIT HealthCare is pleased to announce its partnership with Celltrion Healthcare UK Ltd, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to seamlessly support patients with inflammatory bowel disease (IBD) and their healthcare providers.
Modifying two-week wait protocol for suspected head and neck cancer patients during COVID-19
As healthcare workers, we are committed to ensuring that our patients continue to receive the optimum care that we are set up to deliver. However, the last year has shown that we need to be mindful of balancing this with...In conversation with Dr Abitbol- a Q&A by Vasasnt Oswal
Interview by Vasant Oswal of Dr Abitbol, Ancien Chef de Clinique at the University of Paris, France. Vasant Oswal Dr Abitbol Dr Abitbol developed innovative diagnostic and therapeutic techniques, which include vocal dynamic exploration to look at the vocal folds...ENT in this issue...FESS - The Stammberger Legacy (May/Jun19)
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK E: d.costello@nhs.net Claire Hopkins, FRCS(ORLHNS) DM (Oxon),Guy’s and St Thomas’ Hospitals, London; Professor of Rhinology, King’s College London, UK....BIOHIT launches new quick test to help streamline gastroscopy referrals
BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.
MRI scanning patients with cochlear implants and auditory brainstem implants
In the last five to six decades, MRI scanning has gone from physics experiments in Nottingham University through to Nobel prize-winning work by Sir Peter Mansfield and Paul Lauterbur, to a ‘routine’ imaging modality with an estimated 60 million MRI...
